Effect of Standard vs Intensive Blood Pressure Control on the Risk of Recurrent Stroke

JAMA Neurology - Tập 76 Số 11 - Trang 1309 - 2019
Kazuo Kitagawa1, Yasumasa Yamamoto2, Hisatomi Arima3, Toshiki Maeda3, Norio Sunami4, Takao Kanzawa5, Katsumi Eguchi6, Kenji Kamiyama7, Kazuo Minematsu8, Shinichiro Ueda9, Hiromi Rakugi10, Yusuke Ohya11, Takahide Kohro12, Koji Yonemoto13, Yasushi Okada14, Jitsuo Higaki15, Norio Tanahashi16, Genjiro Kimura17, Satoshi Umemura18, Masayasu Matsumoto19, Kazuaki Shimamoto20, Sadayoshi Ito21, Takao Saruta22, Kazuyuki Shimada23
1Department of Neurology, Tokyo Women’s Medical University, Shinjuku, Tokyo, Japan
2Department of Neurology, Kyoto Katsura Hospital, Nishikyo, Kyoto, Japan
3Department of Preventive Medicine and Public Health, Fukuoka University Faculty of Medicine, Jyonan, Fukuoka, Japan
4Department of Neurosurgery, Fukuzumi Hospital, Matsuyama, Ehime, Japan
5Department of Stroke Medicine, Institute of Brain and Blood Vessel, Mihara Memorial Hospital, Isesaki, Gunnma, Japan
6Department of Internal Medicine, Hanyu General Hospital, Hanyu, Saitama, Japan
7Department of Neurosurgery, Nakamura Memorial Hospital, Sapporo, Hokkaido Japan
8General of the Hospital, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan
9Department of Clinical Pharmacology and Therapeutics, University of the Ryukyus School of Medicine, Nakagamigunn, Okinawa, Japan
10Department of Geriatric and General Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan
11Department of Cardiovascular Medicine, Nephrology and Neurology, University of the Ryukyus School of Medicine, Nakagamigunn, Okinawa, Japan
12Department of Cerebrovascular Medicine, Jichi Medical School, Shimotsuke, Tochigi, Japan
13Department of Environmental Health, University of the Ryukyus School of Medicine, Nakagamigunn, Okinawa, Japan
14Department of Cerebrovascular Medicine and Neurology, National Hospital Organization Kyushu Medical Center Clinical Research Institute, Chuo, Fukuoka, Japan
15Minami-Matsuyama Hospital, Matsuyama, Ehime, Japan
16Department of Neurology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan
17Cardio-renal and Health Research Institute, Nagoya, Aichi, Japan
18Yokohama Rosai Hospital, Yokohama, Kanagawa, Japan
19Sakai City Medical Center, Sakai, Osaka, Japan
20Japan Health Care College, Sapporo, Hokkaido, Japan
21Department of Nephrology Endocrinology and Vascular Medicine, Tohoku University School of Medicine, Sendai, Miyagi, Japan
22Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
23Shin-Oyama City Hospital, Oyama, Tochigi, Japan

Tóm tắt

Từ khóa


Tài liệu tham khảo

Feigin, 2014, Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010 [published correction appears in Lancet. 2014;383(9913):218.]., Lancet, 383, 245, 10.1016/S0140-6736(13)61953-4

Staessen, 2001, Cardiovascular protection and blood pressure reduction: a meta-analysis., Lancet, 358, 1305, 10.1016/S0140-6736(01)06411-X

Gueyffier, 1997, Effect of antihypertensive treatment in patients having already suffered from stroke: gathering the evidence., Stroke, 28, 2557, 10.1161/01.STR.28.12.2557

PROGRESS Collaborative Group, 2001, Randomised trial of a perindopril-based blood-pressure–lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack., Lancet, 358, 1033, 10.1016/S0140-6736(01)06178-5

Liu, 2009, Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature., Hypertens Res, 32, 1032, 10.1038/hr.2009.139

Rashid, 2003, Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review., Stroke, 34, 2741, 10.1161/01.STR.0000092488.40085.15

Katsanos, 2017, Blood pressure reduction and secondary stroke prevention: a systematic review and metaregression analysis of randomized clinical trials., Hypertension, 69, 171, 10.1161/HYPERTENSIONAHA.116.08485

Lewington, 2002, Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies., Lancet, 360, 1903, 10.1016/S0140-6736(02)11911-8

Arima, 2006, Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial., J Hypertens, 24, 1201, 10.1097/01.hjh.0000226212.34055.86

Benavente, 2013, Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial., Lancet, 382, 507, 10.1016/S0140-6736(13)60852-1

Wright, 2015, A randomized trial of intensive versus standard blood-pressure control [published correction appears at N Engl J Med. 2017;377(25):2506]., N Engl J Med, 373, 2103, 10.1056/NEJMoa1511939

Zonneveld, 2018, Blood pressure–lowering treatment for preventing recurrent stroke, major vascular events, and dementia in patients with a history of stroke or transient ischaemic attack., Cochrane Database Syst Rev, 7

Mant, 2016, Different systolic blood pressure targets for people with history of stroke or transient ischaemic attack: PAST-BP (Prevention After Stroke–Blood Pressure) randomised controlled trial., BMJ, 352, i708, 10.1136/bmj.i708

Bath, 2017, Intensive versus guideline blood pressure and lipid lowering in patients with previous stroke: main results from the pilot “Prevention of Decline in Cognition After Stroke Trial” (PODCAST) randomised controlled trial., PLoS One, 12, 10.1371/journal.pone.0164608

Yusuf, 2008, Telmisartan to prevent recurrent stroke and cardiovascular events., N Engl J Med, 359, 1225, 10.1056/NEJMoa0804593

Salam, 2019, Effects of blood pressure lowering on cardiovascular events, in the context of regression to the mean: a systematic review of randomized trials., J Hypertens, 37, 16, 10.1097/HJH.0000000000001994

Zanchetti, 2014, Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension–Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial., J Hypertens, 32, 1888, 10.1097/HJH.0000000000000254

Lawes, 2003, Blood pressure and cardiovascular disease in the Asia Pacific region., J Hypertens, 21, 707, 10.1097/00004872-200304000-00013

Shimamoto, 2014, The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2014)., Hypertens Res, 37, 253, 10.1038/hr.2014.20

Thông tin
Thông tin xuất bản

JAMA Neurology

Tập 76 Số 11

1309

Thông tin tác giả